Growth Metrics

KalVista Pharmaceuticals (KALV) Shareholder's Equity (2014 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 595,226.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.08 Bn
10 KalVista Pharmaceuticals 1.44 Bn 1.25 Bn 56.41 Mn 40.79 Mn

Historic Data

Download Data 🔒
DateValue
Jul 31, 2025 40.79 Mn
Apr 30, 2025 95.39 Mn
Dec 31, 2024 164.36 Mn
Oct 31, 2024 133.99 Mn
Jul 31, 2024 172.80 Mn
Apr 30, 2024 206.58 Mn
Jan 31, 2024 88.58 Mn
Oct 31, 2023 114.45 Mn
Jul 31, 2023 139.34 Mn
Apr 30, 2023 161.03 Mn
Jan 31, 2023 184.44 Mn
Oct 31, 2022 143.81 Mn
Jul 31, 2022 164.57 Mn
Apr 30, 2022 185.09 Mn
Jan 31, 2022 207.94 Mn
Oct 31, 2021 227.47 Mn
Jul 31, 2021 244.43 Mn
Apr 30, 2021 257.19 Mn
Jan 31, 2021 58.57 Mn
Oct 31, 2020 64.98 Mn
Jul 31, 2020 74.44 Mn
Apr 30, 2020 83.75 Mn
Jan 31, 2020 89.75 Mn
Oct 31, 2019 97.79 Mn
Jul 31, 2019 101.87 Mn
Apr 30, 2019 96.74 Mn
Jan 31, 2019 104.03 Mn
Oct 31, 2018 106.95 Mn
Jul 31, 2018 26.25 Mn
Apr 30, 2018 27.25 Mn
Jan 31, 2018 28.57 Mn
Oct 31, 2017 31.08 Mn
Jul 31, 2017 26.74 Mn
Apr 30, 2017 31.33 Mn
Jan 31, 2017 34.85 Mn
Mar 31, 2016 43.07 Mn
Dec 31, 2015 49.31 Mn
Sep 30, 2015 54.62 Mn
Jun 30, 2015 59.32 Mn
Mar 31, 2015 -48.97 Mn
Dec 31, 2014 -44.18 Mn